A Case of Primary Influenza B Pneumonia in Lupus Nephritis Patient on Immunosuppressive Treatment.
10.4078/jrd.2011.18.3.193
- Author:
So Yeon PARK
1
;
Jae Gon LEE
;
Wan Sik UHM
;
Sang Cheol BAE
;
Yoon Kyoung SUNG
Author Information
1. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea. sungyk@hanyang.ac.kr
- Publication Type:Case Report
- Keywords:
Influenza;
Systemic lupus erythematous;
Pneumonia;
Cyclophosphamide
- MeSH:
Accounting;
Adult;
Communicable Diseases;
Cyclophosphamide;
Cytomegalovirus;
Diagnosis, Differential;
Dyspnea;
Female;
Humans;
Influenza, Human;
Lung;
Lung Diseases;
Lung Diseases, Interstitial;
Lupus Nephritis;
Oseltamivir;
Pneumocystis jirovecii;
Pneumonia;
Viruses
- From:Journal of Rheumatic Diseases
2011;18(3):193-196
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Infectious diseases, particularly pneumonia, remain a major cause of morbidity and mortality in patients with systemic lupus erythematous (SLE), accounting for 30~50% of all death. Because infection appears in various forms in lupus patients, early detection and appropriate treatment is very important. In the case of diffuse infiltration in the whole lung field, we should make a differential diagnosis with drug-induced pneumonitis, interstitial lung disease and pneumonia caused by atypical microorganism infection. In particular, in case of atypical microorganism pneumonia, we usually suspect cytomegalovirus, pneumocystis jiroveci and ebstein-barr virus, but influenza pneumonia is relatively neglected. Here, we report on the case of a 26-year-old female patient with lupus nephritis who presented with dyspnea and diffuse pulmonary infiltration immediately after intravenous cyclophosphamide. She was diagnosed with primary influenza B pneumonia and successfully treated with oseltamivir.
